Agenda Cardiomyopathy Symposium 2023
Saturday, September 23, 2023
7 a.m.
Registration, Breakfast & View Exhibits
7:15-8 a.m.
Non-CME Breakfast Symposium Hosted by Pfizer
7:55 a.m.
Welcome and Educational Overview
Rajeev Mohan, MD
SESSION I: CARDIOMYOPATHIES
8 a.m.
Transthyretin Amyloidosis (ATTR): Who to Suspect
Rajeev Mohan, MD
8:20 a.m.
How To Make the Diagnosis of ATTR
Brett Sperry, MD
8:40 a.m.
Current Treatments for ATTR
Rola Khedraki, MD
9 a.m.
Emerging Therapies for ATTR
Jan Griffin, MD
9:20 a.m.
AL Amyloidosis: Making the Diagnosis
Michaela Liedtke, MD
9:40 a.m.
Current and Emerging Treatments for AL Amyloidosis
Robert Vescio, MD
10 a.m.
Panel Discussion/Q&A
10:20 a.m.
Break & View Exhibits
10:50 a.m.
Cardiac Sarcoidosis: Making the Diagnosis
Ajay Srivastava, MD
11:10 a.m.
Cardiac Sarcoidosis: Therapeutic Principles
Ronald Witteles, MD
11:30 a.m.
Hypertrophic Cardiomyopathy: Diagnosis and Treatment
Anjali Owens, MD
11:50 a.m.
Genetic Cardiomyopathies: Who to Screen and What to Look For
Chad Weldy, MD, PhD
12:10 p.m.
Panel Discussion/Q&A
12:30 p.m.
Lunch Break
12:30-1:15 p.m.
Non-CME Lunch Symposium Hosted by AstraZeneca
SESSION II: CARDIO-ONCOLOGY
1:20 p.m.
Best Practices in Surveillance and Management of Cardiac Toxicity in the Cancer Patient: The Oncologist's Perspective
Carrie Costantini, MD
1:40 p.m.
Best Practices in Surveillance and Management of Cardiac Toxicity in the Cancer Patient: The Cardiologist's Perspective
Margot Davis, MD, MSc
2 p.m.
Incorporating Multi-Modality Imaging in Cardio-Oncology
Purvi Parwani, MBBS
2:20 p.m.
Strategies to Minimize Radiation-Induced Heart Disease
Prabhakar Tripuraneni, MD
2:40 p.m.
Panel Discussion/Q&A
3 p.m.
Break & View Exhibits
3:15 p.m.
Management of VTE in the Cancer Patient
Scott Cameron, MD, PhD
3:35 p.m.
Management of End-Stage Heart Failure in the Cancer Survivor
Brian Hardaway, MD
3:55 p.m.
Cardiac Disease Monitoring in Cancer Survivors
Ann Kuo, MD
4:15 p.m.
Panel Discussion/Q&A
4:30 p.m.
Adjourn
**Topics, times, and speakers subject to change